|
DTX Clinical Trials
1 actively recruiting trial across 1 location
Pipeline
Phase 1/2: 1
Top Sponsors
- National Cancer Institute (NCI)1
Indications
- Carcinoma of Larynx1
- Paranasal Sinus Neoplasms1
- Adenoid Cystic Carcinoma1
- Oral Squamous Cell Carcinoma1
- Oropharyngeal Squamous Cell Carcinoma1
Bethesda, Maryland1 trial
Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer
National Institutes of Health Clinical Center
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.